Status:
COMPLETED
Optic Nerve Sheath Ultrasound During Electroconvulsive Therapy
Lead Sponsor:
İrem AKSOY
Collaborating Sponsors:
Cukurova University Medical Faculty Hospital
Conditions:
Intracranial Pressure Change
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Electroconvulsive therapy (ECT) is an effective method that has been used for many years in the treatment of psychiatric disorders and is currently administered under general anesthesia. This study ev...
Detailed Description
Electroconvulsive therapy (ECT) is a treatment method that has been used effectively for many years in the treatment of psychiatric disorders. Typical uses of ECT include depression, schizophrenia, bi...
Eligibility Criteria
Inclusion
- 18 years and older
- ASA 1,2,3
- Participants with various psychiatric problems requiring ECT
Exclusion
- Intracranial mass, edema, or bleeding observed on MRI scan
- previous eye surgery
- severe cataracts
- glaucoma
- optic atrophy
- other severe sight impairment
- traumatic brain injury, space-occupying, and inflammatory lesions
Key Trial Info
Start Date :
June 3 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 23 2022
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT06607679
Start Date
June 3 2022
End Date
November 23 2022
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cukurova University Faculty of Medicine Hospital
Adana, Sariçam, Turkey (Türkiye), 01330